Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | tyrosine kinase | 0.0129013 | 0.0828278 | 1 |
Mycobacterium ulcerans | imidazoleglycerol-phosphate dehydratase | 0.0919286 | 1 | 0.5 |
Schistosoma mansoni | tyrosine kinase | 0.0129013 | 0.0828278 | 1 |
Loa Loa (eye worm) | TK/INSR protein kinase | 0.0129013 | 0.0828278 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0100141 | 0.0493197 | 0.589461 |
Schistosoma mansoni | metabotropic glutamate receptor 2 3 (mglur group 2) | 0.00924921 | 0.0404431 | 0.48828 |
Echinococcus granulosus | insulin growth factor 1 receptor beta | 0.0129013 | 0.0828278 | 1 |
Brugia malayi | Metabotropic glutamate receptor precursor. | 0.00813435 | 0.0275043 | 0.322179 |
Schistosoma mansoni | tyrosine kinase | 0.00586857 | 0.00120825 | 0.0145875 |
Plasmodium falciparum | phosphatase, putative | 0.00666456 | 0.0104463 | 0.5 |
Echinococcus multilocularis | insulin growth factor 1 receptor beta | 0.0129013 | 0.0828278 | 1 |
Schistosoma mansoni | polynucleotide kinase-3'-phosphatase | 0.00666456 | 0.0104463 | 0.126121 |
Echinococcus multilocularis | insulin receptor | 0.0129013 | 0.0828278 | 1 |
Schistosoma mansoni | metabotropic glutamate receptor | 0.00681408 | 0.0121816 | 0.147071 |
Entamoeba histolytica | polynucleotide kinase-3-phosphatase, putative | 0.00666456 | 0.0104463 | 0.5 |
Brugia malayi | Protein kinase domain containing protein | 0.00713678 | 0.0159268 | 0.180331 |
Trypanosoma cruzi | polynucleotide kinase 3'-phosphatase, putative | 0.00666456 | 0.0104463 | 0.5 |
Mycobacterium tuberculosis | Probable imidazole glycerol-phosphate dehydratase HisB | 0.0919286 | 1 | 0.5 |
Echinococcus granulosus | bifunctional polynucleotide | 0.00666456 | 0.0104463 | 0.113184 |
Mycobacterium leprae | Probable imidazole glycerol-phosphate dehydratase HisB | 0.0455288 | 0.461495 | 0.5 |
Plasmodium falciparum | bifunctional polynucleotide phosphatase/kinase | 0.00666456 | 0.0104463 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.00666456 | 0.0104463 | 0.113184 |
Plasmodium vivax | bifunctional polynucleotide phosphatase/kinase, putative | 0.00666456 | 0.0104463 | 0.5 |
Schistosoma mansoni | tyrosine kinase | 0.00586857 | 0.00120825 | 0.0145875 |
Echinococcus granulosus | metabotropic glutamate receptor 2 | 0.00681408 | 0.0121816 | 0.134445 |
Echinococcus multilocularis | metabotropic glutamate receptor 2 | 0.00681408 | 0.0121816 | 0.134445 |
Echinococcus multilocularis | bifunctional polynucleotide | 0.00666456 | 0.0104463 | 0.113184 |
Loa Loa (eye worm) | hypothetical protein | 0.00703267 | 0.0147185 | 0.165527 |
Schistosoma mansoni | tyrosine kinase | 0.00586857 | 0.00120825 | 0.0145875 |
Trypanosoma brucei | polynucleotide kinase 3'-phosphatase, putative | 0.00666456 | 0.0104463 | 0.5 |
Brugia malayi | Protein kinase domain containing protein | 0.0129013 | 0.0828278 | 1 |
Plasmodium vivax | phosphatase, putative | 0.00666456 | 0.0104463 | 0.5 |
Brugia malayi | metabotropic glutamate receptor subtype 5a (mGluR5a), putative | 0.00736951 | 0.0186277 | 0.213423 |
Loa Loa (eye worm) | glutamate receptor | 0.00813435 | 0.0275043 | 0.322179 |
Trypanosoma cruzi | polynucleotide kinase 3'-phosphatase, putative | 0.00666456 | 0.0104463 | 0.5 |
Onchocerca volvulus | Bifunctional polynucleotide phosphatase\/kinase homolog | 0.00666456 | 0.0104463 | 0.5 |
Echinococcus granulosus | insulin receptor | 0.0129013 | 0.0828278 | 1 |
Echinococcus granulosus | metabotropic glutamate receptor 5 | 0.0100141 | 0.0493197 | 0.589461 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.00666456 | 0.0104463 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.00666456 | 0.0104463 | 0.5 |
Echinococcus multilocularis | metabotropic glutamate receptor 5 | 0.0100141 | 0.0493197 | 0.589461 |
Brugia malayi | DNA 3'-phosphatase family protein | 0.00666456 | 0.0104463 | 0.113184 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 0.09 % | Antimalarial activity against Plasmodium berghei infected in NMRI mouse assessed as parasitized red blood cells level at 100 mg/kg, po administered on day 0, 1, 2 and 3 after postinfection measured on day 4 (Rvb = 78%) | ChEMBL. | 21875063 |
Activity (functional) | = 0.3 % | Antimalarial activity against Plasmodium berghei infected in NMRI mouse assessed as parasitized red blood cells level at 30 mg/kg, po administered on day 0, 1, 2 and 3 after postinfection measured on day 4 (Rvb = 78%) | ChEMBL. | 21875063 |
Activity (functional) | = 99.6 % | Antimalarial activity against Plasmodium berghei infected in NMRI mouse assessed as reduction of parasitemia level at 30 mg/kg, po administered on day 0, 1, 2 and 3 after postinfection (Rvb = 0.38%) | ChEMBL. | 21875063 |
Activity (functional) | = 99.9 % | Antimalarial activity against Plasmodium berghei infected in NMRI mouse assessed as reduction of parasitemia level at 100 mg/kg, po administered on day 0, 1, 2 and 3 after postinfection (Rvb = 0.12%) | ChEMBL. | 21875063 |
IC50 (functional) | = 140 nM | Antimalarial activity against erythrocyte stages of chloroquine-sensitive Plasmodium falciparum D10 infected in human erythrocytes by lactate dehydrogenase assay | ChEMBL. | 21875063 |
IC50 (binding) | = 58 uM | Inhibition of chloroquine-resistant Plasmodium falciparum Dd2 chloroquine resistance transporter expressed in xenopus laevis oocytes assessed as inhibition of [3H]chloroquine uptake after 1 to 2 hrs | ChEMBL. | 21875063 |
Ratio IC50 (functional) | = 0.9 | Resistance index, ratio of IC50 for chloroquine-resistant Plasmodium falciparum K1 to IC50 for chloroquine-sensitive Plasmodium falciparum D10 | ChEMBL. | 21875063 |
Time (functional) | = 20.7 day | Antimalarial activity against Plasmodium berghei infected in NMRI mouse assessed as host survival time at 30 mg/kg, po administered on day 0, 1, 2 and 3 after postinfection (Rvb = 4 days) | ChEMBL. | 21875063 |
Time (functional) | = 30 day | Antimalarial activity against Plasmodium berghei infected in NMRI mouse assessed as host survival time at 100 mg/kg, po administered on day 0, 1, 2 and 3 after postinfection (Rvb = 4 days) | ChEMBL. | 21875063 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | 21875063 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.